Sulfobacins A and B, Novel von Willebrand Factor Receptor Antagonists: I. Production, Isolation, Characterization and Biological Activities

Tsutomu Kamiyama, Takayuki Umino, Tomoko Satoh, Sayoko Sawairi, Michiko Shirane, Shoichi Ohshima, Kazuteru Yokose

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Sulfobacins A and B, novel von Willebrand factor (vWF) receptor antagonists, have been isolated from the culture broth of Chryseobacterium sp. (Flavobacterium sp.) NR 2993 by ethyl acetate extraction, and by Sephadex LH-20 and silica gel column chromatographies. The physico-chemical properties of the sulfobacins indicate that their structures are completely different from that of aurintricarboxylic acid, the one known vWF receptor antagonist. Sulfobacins A and B inhibit the binding of vWF to its receptor with IC50s of 0.47 and 2.2 μM, respectively. Sulfobacin A also inhibits ristocetin-induced agglutination in human platelets fixed with paraformaldehyde with an IC50 of 0.58 μM.

Original languageEnglish
Pages (from-to)924-928
Number of pages5
JournalThe Journal of Antibiotics
Volume48
Issue number9
DOIs
Publication statusPublished - Jan 1 1995

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Drug Discovery

Fingerprint Dive into the research topics of 'Sulfobacins A and B, Novel von Willebrand Factor Receptor Antagonists: I. Production, Isolation, Characterization and Biological Activities'. Together they form a unique fingerprint.

  • Cite this